The Protective Effect of Mask Wearing Against Respiratory Tract Infections
NCT05690516 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4575
Last updated 2023-11-29
Summary
In this trial the researchers plan to recruit 4,000 volunteers to be randomly allocated either wearing face masks in public spaces where they are close to other people, or not wear face masks in such circumstances. For each participant the trial period is 2 weeks, after which they will be asked to complete a brief questionnaire which includes questions about whether they experienced the common cold, influenzas or COVID-19 symptoms during the trail period.
Conditions
- COVID-19
- Respiratory Tract Infections
Interventions
- BEHAVIORAL
-
Wearing face masks
Participants are asked to wear face masks in public spaces.
Sponsors & Collaborators
-
University of Basel
collaborator OTHER -
Norwegian Institute of Public Health
lead OTHER_GOV
Principal Investigators
-
Runar Solberg, PhD · Norwegian Institute of Public Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-02-10
- Primary Completion
- 2023-05-01
- Completion
- 2023-05-01
Countries
- Norway
Study Locations
More Related Trials
-
A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized
NCT05799495 ·Status: COMPLETED ·Phase: PHASE2
-
Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults
NCT00793000 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection
NCT05697055 ·Status: UNKNOWN ·Phase: PHASE4
-
Alleviation of Common Cold Symptoms
NCT06106880 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19
NCT04330586 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients
NCT04360551 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting
NCT04396106 ·Status: TERMINATED ·Phase: PHASE2
-
Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation
NCT04356495 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation
NCT04539262 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Masitinib in Patients With Symptomatic Mild to Moderate COVID-19
NCT05047783 ·Status: UNKNOWN ·Phase: PHASE2
-
Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections
NCT04365725 ·Status: COMPLETED
-
An Outpatient Study Investigating Non-prescription Treatments for COVID-19
NCT04621149 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Efficacy of HH-120 Nasal Spray for Prevention of SARS-CoV-2 Infection in Adult Close Contacts of Individuals Infected With SARS-CoV-2
NCT05765279 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff
NCT04723459 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure
NCT04705597 ·Status: TERMINATED ·Phase: PHASE2
-
A Registry Study of Patients Hospitalized With Confirmed COVID-19
NCT05792865 ·Status: UNKNOWN
-
Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19
NCT04709835 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial
NCT05642910 ·Status: UNKNOWN ·Phase: NA
-
Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness
NCT05689034 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19
NCT06349655 ·Status: COMPLETED
-
Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection
NCT05897541 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)
NCT04575597 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)
NCT04593641 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy and Safety of Azovudine in the Treatment of COVID-19
NCT05675761 ·Status: UNKNOWN